OMS santé publique
On December 4th, The Institut Pasteur International Network (IPIN) participated in a high-level meeting on preparedness in public health emergencies and the...
The Institut Pasteur, set up following the success of the human rabies vaccination with funds from a public appeal launched by the French Academy of Sciences,...
Scientists have recently identified a new defense mechanism used by the body to combat Listeria monocytogenes. Their research reveals that these bacteria...
A team of researchers at the University of Cambridge, The Netherlands Cancer Institute and the Institut Pasteur has identified a protein complex that might...
Document de presse
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker – AP-HP), help define the immunological and virological...
Usher syndrome type III: cochlear gene therapy preserves hair cell synaptic transmission to the auditory neurons
Scientists from the Institut Pasteur, Inserm, Sorbonne University and the Collège de France, working in close collaboration with scientists from the University...
Infravec2 new insect vector research tools: no-cost resources for scientists fighting mosquito-transmitted diseases
In 2017, the European Commission gave its go-ahead to Infravec2, the EU-funded global source for no-cost vector research products and services. In June, 2018,...
Progress in the understanding of the mechanisms of genetic diversification in a major fungal pathogen of humans, Candida albicans
Candida albicans is one of the most formidable fungal species, causing infection in humans. Investigating the structure and reproduction methods of pathogenic...
Document de presse
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United...
The most severe allergic reaction, anaphylaxis (or anaphylactic shock), is the result of an inappropriate immune reaction following the introduction of a...